Introduction
Traumatic brain injury (TBI) is a leading cause of death and disability. The aim of a prediction model is to determine survival and long-term functional outcome for the individual. Accurate and early prognostication is important as it enables improved patient and relative counselling, prioritised rehabilitation goals and rationalised allocation of healthcare resources. In addition, prediction models have a role in assessing the effectiveness of, and comparing, novel therapies, as well as allowing audit and comparison between neurocritical care centres.
Currently there are no universally accepted scoring systems that reliably predict outcomes in adult patients following TBI. This article reviews the most recent work related to outcome prediction following TBI and focuses on answering the following questions: • Why is predicting outcome after traumatic brain injury so difficult? • Which clinical variables and scoring systems are used to assist in outcome prediction following TBI? • Which new variables are being studied that could be used to create a more comprehensive and accurate prediction model?
Materials and methods
MEDLINE and EMBASE (1995-current) searches using the National Library for Health, searching keywords (title and abstract): (Predicting AND outcome AND after AND traumatic AND brain OR head AND injury). The initial literature search revealed 278 potential articles. The search was limited to recent (post-2000) articles in English language only, leaving 56 unique articles for examination. Paediatric studies were excluded. Individual articles were reviewed for relevance, in addition to hand searching of their references for other relevant publications. Earlier published articles were considered if they were thought to be particularly relevant to the questions posed in this review.
Results
Why is predicting outcome after traumatic brain injury so difficult?
The reasons for this are complex, and related to a number of factors:
• The nature of the primary brain injury is extremely heterogeneous. No two injuries will be exactly the same. • The primary injury will be modified by secondary insults and patient factors. Premorbid state and physiological reserve also affect how the patient will respond to the trauma and aftermath. • Endpoints are difficult to standardise, and categorising is often too insensitive. Defining 'good' and 'poor' outcome is difficult, and what may be a good outcome for one person, could be a poor outcome for another. Current scales are
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The purpose of this review is to look at the most recent work carried out on predicting outcome after traumatic brain injury (TBI). TBI is a leading cause of death and disability but prediction of long-term outcome for individual patients is difficult. In particular, predicting outcome in the first few hours or days after injury is limited by the paucity of scoring systems or clinical models available. Many clinical variables have been studied to determine if they may play a role in outcome prediction, including age, admission Glasgow Coma Score and pupillary reactivity. Newer variables being studied include serum biomarkers, abnormalities seen on magnetic resonance imaging and data obtained from evoked potentials and electroencephalography studies. There are many factors that impact on outcome and a perfect model is yet to be developed. Models must take into account the economic status of the country in which the trauma occurs. It is important that less affluent nations are not left behind in the search for accurate prognostic modelling. often limited by their arbitrary categories. The Glasgow Outcome Scale (GOS) is popular due to its simplicity and ease of use, but limited by its broad and inflexible categories. Created in 1975, its aim is to categorise patients recovering from TBI into five groups depending upon their ability to perform activities of daily living and the amount of supervision they need ( Table 1) . Work by King et al 1 looked at predicting outcome using the GOS at three and 12 months post-TBI. One hundred and fiftynine patients with severe TBI (GCS ≤8 on admission) had neuropsychiatric assessment at three, six and 12 months postinjury. Multivariate logistic regression analysis showed that GOS at three months was the strongest independent predictor of outcomes at 12 months. They also found prolonged hypotension, diffuse axonal injury and fixed dilated pupils on admission to be significant independent predictors of poor outcome at 12 months. The Extended Glasgow Outcome Scale (GOSE) incorporates a structured interview process and extends the categories from five to eight. This gives greater sensitivity for detecting changes in condition over time and improves accuracy when assessing ongoing treatment or care needs. 2
Which clinical variables and scoring systems are used to assist in outcome prediction following traumatic brain injury?
Many clinical variables have been used in isolation or combination to help in the prediction of outcome following TBI. Signorini et al 3 looked at a cluster of variables that are easily available from early in a patient' s admission: age, Glasgow Coma Score (GCS), injury severity score (ISS), pupil reactivity and presence of haematoma on computed tomography (CT). The authors found each variable to be individually useful in predicting outcome, and produced a model that combined data to predict probability of survival at one year. What this study demonstrated was that simple, readily available data can be used to predict survival.
Work by De Guise et al 4 aimed to predict functional outcome after TBI to allow planning of care and resource allocation at discharge from acute care. This retrospective cohort study excluded patients who had been exposed to alcohol or substance abuse, as well as those with a premorbid history of psychiatric problems. Unfortunately, this limits the clinical application, since many head injuries are the result of -or temporally related to -these factors. Using the Functional Independence Measure (FIM) to assess initial disability, progress and residual limitations, the authors created a composite score that allowed each variable to be assessed individually. The best predictor of outcome found was duration of post-traumatic amnesia in the first seven days after TBI. However, this would not enable prognostication on admission to hospital. Other factors found to be predictive were age, GCS on admission, the need for neurosurgical intervention, the presence of a parietal lesion on CT and the pre-morbid educational status of the patient. They commented that GCS had a better role in predicting mortality following TBI, rather than predicting functional outcome in survivors. The authors felt that the presence of a parietal lesion following trauma may simply be a sign of a more diffuse or severe injury, since the most commonly affected lobes are the temporal and frontal. Parietal injuries are associated with lethargy, and they proposed that this is why these patients score poorly on the FIM. The authors debated whether a higher pre-morbid educational level meant more robust cortical connections that are less likely to be damaged following trauma, or simply more motivated patients in rehabilitation environments.
A recent, large study was carried out by the MRC CRASH Collaborators 5 looking at two different model designs, building on the variables previously found to have some predictive qualities, and taking into account the financial status of the country in which the patient was injured. Data was used from the Medical Research Council (MRC) CRASH (Corticosteroid Randomisation After Significant Head injury) trial, the largest clinical trial conducted in patients with TBI, consisting of a cohort of 10,008 patients. Few data were missing from the original trial, allowing analysis of the complete patient cohort.
The basic model looked at demographic and clinical variables only. It used four easily determined parameters: age, GCS, pupil reactivity and the presence or not of a major extracranial injury. The CT model also took into account results from computed tomography (CT) images; the presence of petechial haemorrhages, obliteration of the third ventricle or basal cisterns, subarachnoid haemorrhage, midline shift and non-evacuated haematoma.
In the basic model, similar to the previous studies, GCS was found to be an important predictor of outcome, especially in low-middle income countries; age was an important predictor in high-income countries. Absence of pupil reactivity was the third strongest predictor found in this study. The CT model found that obliteration of the third ventricle and midline shift were strongest at predicting mortality at 14 days, while nonevacuated haematoma was the strongest predictor of nonfavourable outcome at six months.
The strength of this study is that there was both internal validation as well as external validation (of high-income countries only), using the 8,509 patient cohort from the IMPACT (International Mission for Prognosis And Clinical Trial) database. The MRC CRASH data enabled the collaborators to produce a web-based calculator that formulates a percentage prediction of 14-day mortality and risk of unfavourable outcome at six months post-injury. The calculator adapts depending on whether CT data is available and is therefore of use in both high-and low-middle income countries. Once again, however, the use of the dichotomy 'unfavourable' versus 'favourable' may fail to fully describe an individual patient' s future.
The study using the IMPACT Database 6 prospectively collected data from 11 studies involving patients with moderate or severe TBI, between 1984 and 1997. The purpose of the database was to produce a model that could be used to predict outcome after TBI at the point of admission to hospital, rather than at 24 hours, when traditionally it was easier to make predictions. This study concentrated on outcomes at six months. The investigators selected from 26 potential predictors to create three prognostic models: 1. The core model: Age, motor score component from GCS, and pupillary reactivity.
2. The extended model: As above, with additional information on secondary insults (for example, hypoxia), CT findings, traumatic subarachnoid haemorrhage and epidural haematoma. 3. The lab model: As for the extended model with additional information on haemoglobin and blood sugar. Like the MRC CRASH Trial Collaborators' study, the strongest predictors found were age, motor score, pupillary reactivity and CT characteristics, including the presence of traumatic subarachnoid haemorrhage. A score chart was created which, by adding together points gained for each variable, and for each model, could be plotted against risk of mortality or unfavourable outcome at six months post-TBI. The authors reported that 'all predictors had statistically significant associations with six months' GOS in univariate and multivariable analyses.'
The strength of the IMPACT study was the cross-validation with both the original dataset and externally, using selected patients from the MRC CRASH trial dataset. One limitation of external validation was heterogeneity of the original data collected between MRC CRASH and IMPACT, leading to just the core model, and a modified form of the extended model, being validated. Another limitation was that only selected patients from the MRC CRASH trial could be used. Owing to the excess mortality in the treatment (48-hour infusion of methylprednisolone) arm of the trial, only patients from the placebo arm (n=3,287) and those from high-income countries (n=1,588) could be used.
CT imaging has been used extensively in several studies to help in the prediction of outcome after TBI. In 1991, the Marshall CT classification of traumatic brain injury 7 was produced and has since been used to categorise and predict outcomes when added to other patient admission data ( Table 2 ). This classification looks at diffuse injury and mass lesions. Zhu et al 7 argue that with increasing use of early sedation and intubation of severely injured patients, CT findings may be more prognostic than GCS since patients cannot be assessed properly, especially for verbal response.
Which new variables are being studied that could be used to create a more comprehensive and accurate prediction model? Serum biomarkers
Korfias et al 8 studied the relationship between serum levels of a calcium-binding protein found in the cytosol of astroglial and Schwann cells, S-100B, and outcome following head injury. An increase in serum S-110B indicates irreversible astrocyte injury or death. 9 One hundred and two adults with severe TBI were included in this prospective, observational study, measuring serum S-100B protein levels every 24 hours for the first seven days. The authors found that initial S-100B levels were significantly related to pupillary status (p=0.004), CT scan severity (p=0.047) and survival in the first month (p<0.0001). They also found that levels of this marker fell following certain surgical and medical interventions. It was postulated that serum S-100B levels were an indication of injury severity, tracked improvement and deterioration, and helped to predict outcome. Another prospective, observational study looking at S-100B, 10 as well as glial fibrillary acidic protein (GFAP) and neuronal specific enolase (NSE), in severely head-injured patients found that levels of each biomarker were raised on admission to hospital, and were significantly higher in those who died or had a poor outcome.
Plasma cell-free DNA has been investigated as a potential marker for injury severity 11 and prediction of fatal outcomes. Cell-free DNA in the plasma or serum is used to diagnose, prognosticate and monitor a variety of conditions, such as tumour states. Significantly increased levels of plasma DNA have also been found in trauma patients and may occur as a result of tissue necrosis, cellular apoptosis, or decreased efficiency of cell-free DNA clearance. Yurgel et al found that, when compared with controls, patients with TBI had significantly higher plasma DNA concentrations. 11 Plasma DNA concentrations were not higher in patients with extracranial injuries in addition to TBI when compared with patients with isolated TBI. Higher DNA concentrations were significantly associated with fatal outcome when plasma levels were assessed 24 hours after study entry.
Magnetic resonance imaging
Magnetic resonance imaging (MRI) allows assessment of the injured brain, including the brainstem. CT has long been used to identify intracranial haemorrhage, skull fractures and early brainstem injury, which is of use in prognostication following TBI. It has been noted that MRI is more sensitive than CT when looking for intraparenchymal shearing, haemorrhages and injuries to the posterior fossa. A number of different MRI techniques are employed when searching for certain injuries, 12 for example T2-weighted imaging (T2WI) is better for intraparenchymal lesion assessment and fluid-attenuated inversion recovery (FLAIR) is better for oedematous lesions as
Review articles Category Definition
Diffuse injury I No visible intracranial pathology seen on CT scan
Diffuse injury II Cisterns present with midline shift of 0-5 mm and/or lesion densities present; no high or mixed density lesion >25cm 3 , may include bone fragments and foreign bodies Diffuse injury III (swelling) Cisterns compressed or absent with midline shift of 0-5mm; no high or mixed density lesion >25cm 3
Diffuse injury IV (shift) Midline shift >5mm; no high or mixed density lesion >25cm 3
Evacuated mass lesion (V) Any lesion surgically evacuated
Non-evacuated mass lesion (VI) High or mixed density lesion >25cm 3 not surgically evacuated Table 2 Marshall CT classification of traumatic brain injury.
well as anomalies close to the cerebrospinal fluid.
Weiss et al 13 studied the combination of certain clinical features on examination and findings on MRI in order to predict outcome in 73 comatose, severely head-injured, patients. Their prospectively recruited cohort of patients was still mechanically ventilated, with no evidence of awareness at two weeks post-injury, despite withdrawal of sedation 48 hours or more previously. They assessed neurological outcome at one year. They found that all patients with bilateral and symmetrical lesions of the brainstem and diencephalons had a poor outcome. Clusters of injuries, such as 'hypothalamus and basal forebrain' were independently associated with a poor outcome. Grasping and chewing after cessation of sedation were important predictors of poor outcomes in the combined clinical/MRI analysis. Unfortunately, access to suitable MRI facilities and skilled radiology interpretation may limit this method' s wider use.
Tollard et al 14 used a combination of two newer techniques; diffusion tensor imaging (DTI) that assesses water diffusion, and magnetic resonance spectroscopy (MRS) that quantifies metabolite levels, and found them to be 86% sensitive, and 97% specific for predicting unfavourable outcome one year after TBI. Imaging was done sub-acutely, in order to assess both primary and secondary brain injuries. Proton MRS differs from conventional MRI in that the information from protons in water is suppressed, allowing proton signals from other metabolites to be measured. 15 There are seven commonly measured metabolites, and this information can be measured from selected regions. Clinically, this allows an assessment of metabolic changes within the brain after injury. An earlier study by Shutter et al 16 found that changes in certain metabolites soon after injury (within days) could be used to predict poor outcome 6-12 months later.
Evoked potentials
Somatosensory evoked potentials (SEP) 17 are the electrical signals generated by the central nervous system in response to sensory stimulus, even in the presence of general anaesthesia. They represent conduction through the peripheral nervous system, dorsal column of the spinal cord, lemniscal pathways in the brainstem and arrival at the cerebral somatosensory cortex. They are commonly detected using the median nerve at the wrist. Lew et al 18 used median nerve SEP, as well as cognitive event-related potentials (ERP) to predict outcomes following TBI. They studied 22 patients with severe TBI, recording SEPs within eight days of injury. Bilateral studies were performed. Speech-evoked ERP testing was also done within eight days of TBI. Outcome was scored using the GOSE at one, three and six months post-TBI. They found that bilateral absence of cortically recorded median nerve SEP within eight days of severe TBI strongly predicted worst outcomes, and were up to 100% specific for poor outcome at six months post-injury. Predicting good outcomes with SEP or ERP studies was less accurate. Normal ERP was more accurate than normal SEP at predicting GOSE 7-8, and was still the superior predictor when 'good outcome' was expanded to include GOSE 5-8. This study was carried out within eight days of injury, but would not assist in producing a prediction model for patients with TBI on admission to hospital. Detecting and interpreting SEPs and ERPs requires specialist technology and trained personnel, potentially limiting its widespread use.
Electroencephalography
Patterns generated by electroencephalography (EEG) recording 19 can correlate with cerebral blood flow, metabolism and function. Alpha waves can be detected and are marked by frequency, variability and reactivity to stimuli. The source and regulation of alpha waves in humans is not clear, but animal data suggest they originate from, and are controlled by, the thalamus. Previous work has demonstrated correlations between percent alpha variability (PAV) and outcome in aneurysmal subarachnoid haemorrhage or TBI. PAV reduces during subarachnoid haemorrhage-induced vasospasm (causing ischaemia) and normalises with ischaemia reversal. Hebb et al postulated that reduced PAV would predict a poor six-month outcome and correlate to thalamic injury. 'Alpha coma' is a state where anomalous alpha patterns have been described. Reduced PAV in these patients may be a key predictor of a poor outcome. The authors found that low PAV scores predicted poor outcomes, and high PAV scores predicted good outcomes, although intermediate scoring was less accurate. The utility of EEG in predicting outcomes early in the post-injury course is limited by the use of cerebral depressants such as propofol or thiopental.
Conclusion
Predicting outcome following traumatic brain injury is valuable but difficult. To plan and distribute treatment in a just and cost-effective way, with the endpoint of improved satisfaction for professionals, patients and their families, is of paramount importance.
For prognostication to be clinically useful, outcomes must provide a reasonable impression of what life will be like for the patient in the longer term. Dichotomising outcomes into 'good' or 'poor' may not be an accurate enough reflection of the future to justify a change in medical management, or to counsel patients or their families sufficiently. In the future, it will be important to develop prognostic models that will be available for the majority in the world, and not just the privileged few.
